Table 4 GO Term enrichment analysis for BWS-WT modules.
From: Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development
MEgrey | |||||
|---|---|---|---|---|---|
#term ID | Term description | Observed gene count | Background gene count | Strength | False discovery rate |
GO:0006119 | Oxidative phosphorylation | 22 | 118 | 0.56 | 0.0156 |
GO:0046034 | ATP metabolic process | 29 | 204 | 0.44 | 0.0243 |
GO:0022904 | Respiratory electron transport chain | 19 | 107 | 0.54 | 0.0483 |
GO:0042775 | Mitochondrial atp synthesis coupled electron transport | 17 | 87 | 0.58 | 0.0483 |
MEtan | |||||
GO:0000398 | mRNA splicing, via spliceosome | 20 | 294 | 0.54 | Not significant |
MEsalmon | |||||
GO:0006521 | Regulation of cellular amino acid metabolic process | 12 | 64 | 0.67 | 0.0268 |
GO:0061418 | Regulation of transcription from rna polymerase ii promoter in response to hypoxia | 14 | 78 | 0.65 | 0.0178 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 17 | 96 | 0.64 | 0.0101 |
GO:1902036 | Regulation of hematopoietic stem cell differentiation | 13 | 74 | 0.64 | 0.0255 |
GO:0038061 | NIK/NF-kappaB signaling | 14 | 81 | 0.63 | 0.0216 |
GO:0090175 | Regulation of establishment of planar polarity | 18 | 111 | 0.61 | 0.0101 |
GO:0033209 | Tumor necrosis factor-mediated signaling pathway | 20 | 125 | 0.6 | 0.0101 |
GO:0031145 | Anaphase-promoting complex-dependent catabolic process | 13 | 83 | 0.59 | 0.0445 |
GO:0010972 | Negative regulation of g2/m transition of mitotic cell cycle | 14 | 92 | 0.58 | 0.0364 |
GO:0070498 | interleukin-1-mediated signaling pathway | 14 | 96 | 0.56 | 0.0445 |
GO:0035567 | Non-canonical wnt signaling pathway | 18 | 130 | 0.54 | 0.0216 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 16 | 115 | 0.54 | 0.0325 |
